Onward to Cures.

The Guthy-Jackson Charitable Foundation led a science and clinical revolution leading to therapies that save & improve countless lives of patients who face Neuromyelitis Optica (NMO) and related autoimmune diseases. 

Today, four FDA-approved therapies have proven highly effective in preventing NMO relapses and improving patient quality of life. 

Now—we turn our focus and energy to the last mile of our mission:
to cure NMO and other autoimmune diseases—once and for all.

We are Cureageous™.

New Technology.

Welcome to the bold new era of immune tolerization.  We team up with the experts in immune tolerance, autoimmune disease, clinical medicine, AI & beyond to turn cutting edge science into life-changing medicine—at the speed of life.

Harmonizing expertise among biotech, pharma, venture and strategic partners is a hallmark of our pioneering CureTank.

Bringing the best & brightest minds together is our blueprint to drive life-saving saving solutions that cannot be found alone.

We are Innovative.

Retune Immunity.

In autoimmune disease the immune system mistakenly views self as abnormal and attacks—this is termed loss of immune tolerance.  Our mission to cure NMO is a model for solving all autoimmune diseases. 

Autoimmune therapies cause infection & cancer—cancer therapies cause infection & autoimmune disease. This vicious cycle must stop. 

By retuning the immune system, immune tolerance can be restored to end autoimmune disease—and end the risks of lifelong therapy. 

We are Determined.

Change Lives.

Autoimmune diseases are as common as heart disease and twice as common as cancer.  Today, these conditions afflict over 25 million individuals in the U.S. and more than 1 billion worldwide—and rising.

Autoimmune diseases do not just impact patient health.  Families, parenting, careers, education, hopes and dreams are all affected.

Everyone knows someone whose life is impacted by an autoimmune disease.  If we do not aim for cures—we are not aiming high enough.   

We are Inspired.